Influence of post-transplant serum concentration of ATG and Campath-1H on immune recovery in children after stem cell transplantation

被引：0
|
作者：
Zijde, E. Jol-van der [1 ]
Schenk, C. [1 ]
Jansen-Hoogendijk, A. [1 ]
Lankester, A. [1 ]
Bredius, R. [1 ]
Van Tol, M. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S27 / S28
页数：2
相关论文
共 50 条
  • [1] Impact of serotherapy on the outcome after stem cell transplantation in children: ATG versus Campath-1H
    Jol-van der Zijde, C. M.
    Willemsen, L.
    Putter, H.
    Lankester, A. C.
    Bredius, R. G. M.
    van Tol, M. J. D.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S54 - S54
  • [2] Serotherapy in paediatric allogeneic stem cell transplantation: comparison of ATG and Campath-1H as part of conditioning
    Jol-van der Zijde, C. M.
    Jansen-Hoogendijk, A. M.
    Egeler, R.
    Lankester, A. C.
    Bredius, R. G. M.
    van Tol, M. J. D.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S126 - S126
  • [3] High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution
    Chakrabarti, S
    Mackinnon, S
    Chopra, R
    Kottaridis, PD
    Peggs, K
    O'Gorman, P
    Chakraverty, R
    Marshall, T
    Osman, H
    Mahendra, P
    Craddock, C
    Waldmann, H
    Hale, G
    Fegan, CD
    Yong, K
    Goldstone, AH
    Linch, DC
    Milligan, DW
    BLOOD, 2002, 99 (12) : 4357 - 4363
  • [4] Early recovery of T cell immunity in pancreas transplant recipients treated with Campath-1H
    Bentlejewski, C
    Guaspari, D
    Zdanowicz, G
    Girnita, A
    Britz, J
    Kowalski, R
    Glidewell, J
    Thai, N
    Zeevi, A
    HUMAN IMMUNOLOGY, 2005, 66 : S95 - S95
  • [5] ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
    Olaf Penack
    Mouad Abouqateb
    Christophe Peczynski
    William Boreland
    Nicolaus Kröger
    Matthias Stelljes
    Tobias Gedde-Dahl
    Igor Wolfgang Blau
    Thomas Schroeder
    Urpu Salmenniemi
    Alexander Kulagin
    Régis Peffault de Latour
    Stephan Mielke
    Robert Zeiser
    Ivan Moiseev
    Hélène Schoemans
    Christian Koenecke
    Zinaida Peric
    Leukemia, 2024, 38 : 1156 - 1163
  • [6] Steroid- and ATG-resistant rejection after double forearm transplantation responds to Campath-1H
    Schneeberger, S
    Kreczy, A
    Brandacher, G
    Steurer, W
    Margreiter, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (08) : 1372 - 1374
  • [7] ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
    Penack, Olaf
    Abouqateb, Mouad
    Peczynski, Christophe
    Boreland, William
    Kroeger, Nicolaus
    Stelljes, Matthias
    Gedde-Dahl, Tobias
    Blau, Igor Wolfgang
    Schroeder, Thomas
    Salmenniemi, Urpu
    Kulagin, Alexander
    de Latour, Regis Peffault
    Mielke, Stephan
    Zeiser, Robert
    Moiseev, Ivan
    Schoemans, Helene
    Koenecke, Christian
    Peric, Zinaida
    LEUKEMIA, 2024, 38 (05) : 1156 - 1163
  • [8] In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation
    Kottaridis, PD
    Milligan, DW
    Chopra, R
    Chakraverty, RK
    Chakrabarti, S
    Robinson, S
    Peggs, K
    Verfuerth, S
    Pettengell, R
    Marsh, JCW
    Schey, S
    Mahendra, P
    Morgan, GJ
    Hale, G
    Waldmann, H
    de Elvira, MCR
    Williams, CD
    Devereux, S
    Linch, DC
    Goldstone, AH
    Mackinnon, S
    CYTOTHERAPY, 2001, 3 (03) : 197 - 201
  • [9] Impact of Early Immune Reconstitution after Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Dorado, Nieves
    Perez-Corral, Ana
    Kwon, Mi
    Solan, Laura
    Bailen, Rebeca
    Pascual, Cristina
    Serrano, David
    Anguita, Javier
    Balsalobre, Pascual
    Martinez-Laperche, Carolina
    Luis Diez-Martin, Jose
    BLOOD, 2018, 132
  • [10] Reducing pretransplant Campath-1H dose does not prevent early CMV reactivation post allogeneic stem cell transplantation
    Schunn, G
    Devetten, MP
    Craig, M
    Bunner, P
    Beall, C
    Ericson, SG
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 59 - 60
12345